✦ LIBER ✦

Glutathione in Parkinson’s Disease: Application of thiols as a new therapeutic strategy

✍ Scribed by Elżbieta, Lorenc-Koci

Book ID: 122256400
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 61
Category: Article
ISSN: 1734-1140
DOI: 10.1016/S1734-1140(09)70203-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated glutathione as a therapeutic st

Elevated glutathione as a therapeutic strategy in Alzheimer's disease

✍ D. Allan Butterfield; Chava B. Pocernich; Jennifer Drake 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract Alzheimer's disease (AD) is characterized by progressive loss of memory and cognition. Our laboratory and many others have shown that the AD brain is under extensive oxidative stress. Numerous therapeutic approaches to AD therapy have been hypothesized. Among these are exogenous antioxi

RNA knockdown as a potential therapeutic

RNA knockdown as a potential therapeutic strategy in Parkinson's disease

✍ Manfredsson, F P; Lewin, A S; Mandel, R J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB

Elevation of glutathione as a therapeuti

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

✍ Chava B. Pocernich; D. Allan Butterfield 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Neurotransmitter CART as a New Therapeut

Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease

✍ Mao, Peizhong; Meshul, Charles; Thuillier, Philippe; Reddy, P. 📂 Article 📅 2013 🏛 MDPI AG 🌐 English ⚖ 241 KB

LRRK2 as a therapeutic target in Parkins

LRRK2 as a therapeutic target in Parkinson’s disease

✍ E. K. Tan; A. H. Schapira 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The transcription factor Nrf2 as a new t

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease

✍ Cuadrado, Antonio; Moreno-Murciano, Paz; Pedraza-Chaverri, José 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 368 KB